| |
| Issue |
Title |
| |
| Vol 19, No 2 (2025) |
Severe comorbid infections in patients with inflammatory joint diseases: frequency, structure, risk factors |
Abstract
PDF (Rus)
|
|
M. M. Baranova, N. V. Muravyova, B. S. Belov |
| |
| Vol 19, No 2 (2025) |
Osteoarthritis: modern aspects of pathogenesis, focus on low-intensity inflammation |
Abstract
PDF (Rus)
|
|
I. S. Svintsitskaya, D. S. Aganov, K. V. Raimuev, A. S. Merlushkina, M. M. Toporkov, A. I. Zhigulina |
| |
| Vol 19, No 2 (2025) |
Technical features and current trends of hip arthroplasty in patients with ankylosing spondylitis |
Abstract
PDF (Rus)
|
|
I. V. Polevoy, A. A. Roskidaylo, A. M. Lila, M. A. Makarov |
| |
| Vol 19, No 2 (2025) |
Parvovirus B19 infection and its role in rheumatology |
Abstract
PDF (Rus)
|
|
G. I. Gridneva, B. S. Belov, M. S. Tolbeeva, E. S. Aronova |
| |
| Vol 19, No 1 (2025) |
Chronic pain and group B vitamins |
Abstract
PDF (Rus)
|
|
E. V. Zonova, L. I. Alekseeva, A. M. Lila |
| |
| Vol 19, No 1 (2025) |
Adjuvant therapy of osteoarthritis with bioregulatory drugs |
Abstract
PDF (Rus)
|
|
E. G. Zotkin, S. Yu. Shkireeva |
| |
| Vol 19, No 1 (2025) |
Characteristics of systemic lupus erythematosus in patients of Asian ethnicity |
Abstract
PDF (Rus)
|
|
G. M. Koilubaeva, E. A. Aseeva, S. K. Soloviev, A. M. Lila |
| |
| Vol 19, No 1 (2025) |
Known laboratory abnormalities and potential targets for the conservative treatment of avascular osteonecrosis |
Abstract
PDF (Rus)
|
|
V. E. Bialik, M. A. Makarov, E. I. Bialik, S. A. Makarov, A. E. Karateev, A. M. Lila, V. A. Nesterenko, A. A. Bialik, D. V. Kapitonov, A. I. Gorelova |
| |
| Vol 18, No 6 (2024) |
The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies |
Abstract
PDF (Rus)
|
|
E. N. Vorkel, T. M. Reshetnyak, A. M. Lila |
| |
| Vol 18, No 6 (2024) |
Bioanalogues in the treatment of rheumatoid arthritis: current status of the problem |
Abstract
PDF (Rus)
|
|
N. V. Chichasova, A. M. Lila |
| |
| Vol 18, No 6 (2024) |
Modern possibilities of instrumental diagnostics of early stages of avascular osteonecrosis |
Abstract
PDF (Rus)
|
|
V. E. Bialik, M. A. Makarov, E. I. Bialik, S. А. Makarov, A. E. Karateev, A. M. Lila, V. A. Nesterenko, A. A. Bialik, D. V. Kapitonov, A. I. Gorelova |
| |
| Vol 18, No 5 (2024) |
Steroid-sparing strategy for the treatment of vasculitis associated with antineutrophil cytoplasmic antibodies |
Abstract
PDF (Rus)
PDF (Eng)
|
|
O. N. Egorova, G. M. Tarasova, A. V. Datsina, B. G. Issayeva, D. S. Dilmanova, S. M Issayeva, A. M. Lila |
| |
| Vol 18, No 5 (2024) |
Current issues in the practical use of allopurinol in patients with gout and hyperuricemia |
Abstract
PDF (Rus)
|
|
M. S. Eliseev |
| |
| Vol 18, No 5 (2024) |
Is vaccination against viral hepatitis B safe and immunogenic in patients with rheumatic diseases? |
Abstract
PDF (Rus)
PDF (Eng)
|
|
G. I. Gridneva, B. S. Belov, E. S. Aronova |
| |
| Vol 18, No 5 (2024) |
Celecoxib in rheumatic diseases: possibilities and prospects. Brief descriptive survey |
Abstract
PDF (Rus)
|
|
A. E. Karateev |
| |
| Vol 18, No 5 (2024) |
Febuxostat in patients with hyperuricemia and gout: is the nephroprotective effect real? |
Abstract
PDF (Rus)
|
|
M. S. Eliseev, Ya. I. Kuzmina |
| |
| Vol 18, No 4 (2024) |
Vaccination against Herpes zoster in patients with immune-mediated inflammatory rheumatic diseases: new data |
Abstract
PDF (Rus)
|
|
N. V. Muravyova, B. S. Belov |
| |
| Vol 18, No 4 (2024) |
On the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritis |
Abstract
PDF (Rus)
|
|
I. V. Sarvilina, A. M. Lila, O. A. Gromova |
| |
| Vol 18, No 4 (2024) |
Modern treatment options for systemic lupus erythematosus in children (literature review) |
Abstract
PDF (Rus)
|
|
M. I. Kaleda, I. P. Nikishina |
| |
| Vol 18, No 4 (2024) |
Baricitinib: key results of long-term use in rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
N. V. Chichasova, A. M. Lila |
| |
| Vol 18, No 3 (2024) |
Battle of the strategies: diet versus drug therapy for gout |
Abstract
PDF (Rus)
|
|
O. V. Zhelyabina, M. S. Eliseev, A. M. Lila |
| |
| Vol 18, No 3 (2024) |
Peculiar features of intravenous immunoglobulins application in rheumatic diseases |
Abstract
PDF (Rus)
|
|
O. N. Egorova, G. M. Tarasova, A. V. Datsina, E. G. Sazhina |
| |
| Vol 18, No 3 (2024) |
Some features of osteogenesis in ankylosing spondylitis and the possibilities of treatment with bisphosphonates |
Abstract
PDF (Rus)
|
|
A. V. Datsina, S. F. Erdes |
| |
| Vol 18, No 3 (2024) |
Identification of patterns of microbiota influence on the pathogenetic mechanisms of systemic lupus erythematosus development |
Abstract
PDF (Rus)
|
|
A. A. Shaykhutdinova, D. A. Burbeza, S. I. Strelchenko, K. Fathallah, K. P. Rayevsky |
| |
| Vol 18, No 3 (2024) |
Secondary fibromyalgia in children with immune-inflammatory rheumatic diseases |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. V. Santimov, S. V. Grechanyi, G. A. Novik |
| |
| Vol 18, No 3 (2024) |
Local injection therapy with hyaluronic acid preparations: in focus of rheumatologists and orthopedic traumatologists |
Abstract
PDF (Rus)
|
|
A. E. Karateev |
| |
| Vol 18, No 2 (2024) |
Systemic lupus erythematosus with juvenile onset: current status of the problem (literature review) |
Abstract
PDF (Rus)
|
|
M. I. Kaleda, I. P. Nikishina |
| |
| Vol 18, No 2 (2024) |
New molecular aspects of the pathogenesis of osteoporosis – perspectives for early diagnosis and treatment |
Abstract
PDF (Rus)
|
|
A. V. Tyurin, K. E. Akhiyarova, B. I. Yalaev, T. S. Zagidullin, R. I. Khusainova |
| |
| Vol 18, No 1 (2024) |
Modern approaches to the treatment of Takayasu arteritis |
Abstract
PDF (Rus)
|
|
O. N. Egorova, G. M. Tarasova, G. M. Koylubaeva, A. Yu. Sukhanina, I. A. Guseva, A. M. Bolotbekova, G. Suyunbai kyzy, A. T. Turatbekova, A. A. Okunova, A. O. Abdykerimov, T. M. Reshetnyak |
| |
| Vol 18, No 1 (2024) |
The use of biologic therapy in patients with ankylosing spondylitis and coxitis: dynamics of clinical and laboratory parameters and structural progression |
Abstract
PDF (Rus)
|
|
Sh. F. Erdes, V. F. Achikyan, E. M. Agafonova |
| |
| Vol 18, No 1 (2024) |
Diet for gout and hyperuricaemia: some important questions |
Abstract
PDF (Rus)
|
|
O. V. Zhelyabina, M. S. Eliseev, Y. I. Kuzmina |
| |
| Vol 18, No 1 (2024) |
Issues of contraception in rheumatic diseases: current status of the problem and perspectives |
Abstract
PDF (Rus)
|
|
T. S. Panevin, A. A. Smetnik, T. V. Dubinina |
| |
| Vol 17, No 6 (2023) |
New imaging strategy for large vessel vasculitis (based on the EULAR-2023 recommendations) |
Abstract
PDF (Rus)
|
|
O. N. Egorova, G. M. Tarasova, G. M. Koylubaeva, A. M. Bolotbekova, I. A. Guseva, T. M. Reshetnyak, A. T. Turatbekova, G. Suyunbai kyzy, A. O. Abdykerimov, A. A. Okunova |
| |
| Vol 17, No 6 (2023) |
Difficult-to-treat osteoarthritis – justification for multimodal treatment tactics |
Abstract
PDF (Rus)
|
|
A. E. Karateev |
| |
| Vol 17, No 6 (2023) |
Differentiated approach to the treatment of musculoskeletal pain: higher doses of analgesics provide a better effect. A brief narrative review |
Abstract
PDF (Rus)
|
|
A. E. Karateev, A. M. Lila |
| |
| Vol 17, No 5 (2023) |
Arthropathy associated with antitumor checkpoint inhibitors therapy: current understanding of the problem |
Abstract
PDF (Rus)
|
|
A. D. Koltakova, A. M. Lila |
| |
| Vol 17, No 5 (2023) |
Molecular mechanisms regulating uric acid metabolism in the human intestine, systematic literature review |
Abstract
PDF (Rus)
|
|
N. A. Konyshko, G. S. Konyshko |
| |
| Vol 17, No 4 (2023) |
Musculoskeletal symptoms in juvenile onset systemic lupus erythematosus |
Abstract
PDF (Rus)
|
|
M. I. Kaleda, A. N. Arefieva, I. P. Nikishina |
| |
| Vol 17, No 4 (2023) |
Cardiovascular safety of xanthine oxidase inhibitors: an optimistic and unfinished story |
Abstract
PDF (Rus)
|
|
M. S. Eliseev, O. V. Zhelyabina |
| |
| Vol 17, No 4 (2023) |
Autoimmunity and autoinflammation — the key to understanding the pathogenesis of osteoarthritis and developing new ways for its prevention and therapy |
Abstract
PDF (Rus)
|
|
I. V. Sarvilina, A. M. Lila, L. I. Alekseeva, O. A. Gromova, E. A. Taskina |
| |
| Vol 17, No 3 (2023) |
Switching biological disease-modifying antirheumatic drugs and Janus kinase inhibitors in patients with rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
A. O. Bobkova, A. M. Lila |
| |
| Vol 17, No 3 (2023) |
Revisiting the question of the safety of glucocorticoids use of in the treatment of rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
E. A. Aronova, B. S. Belov, G. I. Gridneva |
| |
| Vol 17, No 3 (2023) |
The potential use of DNA double-strand breaks detection in various fields of medicine |
Abstract
PDF (Rus)
|
|
A. V. Torgashina, A. M. Lila |
| |
| Vol 17, No 3 (2023) |
Principles of urate-lowering therapy: eight steps to success |
Abstract
PDF (Rus)
|
|
O. V. Zhelyabina, M. S. Eliseev, A. M. Lila |
| |
| Vol 17, No 2 (2023) |
Treatment of rheumatic diseases. Different nosologies, common problems |
Abstract
PDF (Rus)
|
|
Yu. A. Olyunin |
| |
| Vol 17, No 2 (2023) |
Thrombosis risk factors in ANCA-associated vasculitis |
Abstract
PDF (Rus)
|
|
E. N. Kharlamova, T. M. Reshetnyak, G. M. Tarasova |
| |
| Vol 17, No 2 (2023) |
Clinical variants of skin and mucous membrane lesions in systemic lupus erythematosus with juvenile onset |
Abstract
PDF (Rus)
PDF (Eng)
|
|
M. I. Kaleda, S. O. Salugina, I. P. Nikishina, A. N. Arefieva |
| |
| Vol 17, No 2 (2023) |
Urate-lowering therapy and kidney function |
Abstract
PDF (Rus)
|
|
M. S. Eliseev |
| |
| Vol 17, No 1 (2023) |
Axial spondyloarthritis and COVID-19: course, interactions, outcomes, and the role of vaccination |
Abstract
PDF (Rus)
|
|
Sh. F. Erdes, B. S. Belov |
| |
| Vol 17, No 1 (2023) |
Post-traumatic osteoarthritis: epidemiology, pathogenesis, clinical picture, approaches to pharmacotherapy |
Abstract
PDF (Rus)
|
|
A. E. Karateev, A. A. Chernikova, M. A. Makarov |
| |
| Vol 16, No 6 (2022) |
New etanercept biosimilar — expanding treatment options for immune-mediated inflammatory rheumatic diseases |
Abstract
PDF (Rus)
|
|
A. E. Karateev, A. M. Lila |
| |
| Vol 16, No 6 (2022) |
Osteoarthritis of hand joints: prevalence, risk factors, phenotypes, diagnosis, treatment |
Abstract
PDF (Rus)
|
|
L. I Alekseeva, E. P. Sharapova, A. M. Lila |
| |
| Vol 16, No 5 (2022) |
Infections and systemic vasculitis |
Abstract
PDF (Rus)
|
|
B. S. Belov, O. N. Egorova, G. M. Tarasova, N. V. Muravieva |
| |
| Vol 16, No 5 (2022) |
Shared features of pathogenetic aspects, autoimmunity and pharmacotherapy in coronavirus infection (COVID-19) and immunoinflammatory rheumatic diseases |
Abstract
PDF (Rus)
|
|
K. S. Rutskaya-Moroshan, S. T. Abisheva, A. M. Lila |
| |
| Vol 16, No 5 (2022) |
Hyaluronic acid in rheumatic disorders of the periarticular soft tissues: a brief descriptive review |
Abstract
PDF (Rus)
|
|
A. E. Karateev |
| |
| Vol 16, No 5 (2022) |
Chronic back pain from rheumatologist point of view |
Abstract
PDF (Rus)
|
|
Yu. A. Olyunin, A. M. Lila |
| |
| Vol 16, No 5 (2022) |
Analgesics in rheumatic diseases – a necessary component of therapy aimed at improving the quality of life |
Abstract
PDF (Rus)
|
|
A. E. Karateev |
| |
| Vol 16, No 5 (2022) |
Molecular Mechanisms of Action of Undenatured Type II Collagen: Experimental and Clinical Evidence |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Yu. Torshin, A. M. Lila |
| |
| Vol 16, No 4 (2022) |
Chronic back pain as a spinal osteoarthritis manifestation: rationale and practice of symptomatic slow acting drugs for osteoarthritis use |
Abstract
PDF (Rus)
|
|
A. E. Karateev |
| |
| Vol 16, No 4 (2022) |
Pleiotropic effects of diacerein in comorbid patients with osteoarthritis |
Abstract
PDF (Rus)
|
|
I. B. Belyaeva, V. I. Mazurov |
| |
| Vol 16, No 4 (2022) |
The use of bisphosphonates for the treatment and prevention of osteoporosis |
Abstract
PDF (Rus)
|
|
O. A. Nikitinskaya, N. V. Toroptsova |
| |
| Vol 16, No 4 (2022) |
On the prospects for the use of undenatured type II collagen in the treatment of osteoarthritis and other joint diseases |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Yu. Torshin, A. M. Lila, O. A. Shavlovskaya |
| |
| Vol 16, No 4 (2022) |
Lornoxicam in the treatment of acute and chronic musculoskeletal pain |
Abstract
PDF (Rus)
|
|
E. Yu. Polishchuk, A. E. Karateev |
| |
| Vol 16, No 4 (2022) |
The role of neutrophils in the pathogenesis of Behcet's disease |
Abstract
PDF (Rus)
|
|
K. S. Nurbaeva, T. A. Lisitsyna, A. M. Lila, T. M. Reshetnyak |
| |
| Vol 16, No 4 (2022) |
Evidence-based therapy for knee osteoarthritis: expected short-, medium-, and long-term outcomes of prescription crystalline glucosamine sulfate administration |
Abstract
PDF (Rus)
|
|
L. N. Denisov, L. I. Alekseeva, E. G. Zotkin, I. S. Dydykina, A. M. Lila, S. S. Rodionova, A. Yu. Kochish, E. A. Trofimov, E. Z. Yakupov, S. P. Yakupova, L. N. Eliseeva |
| |
| Vol 16, No 3 (2022) |
Diacerein in the treatment of chronic musculoskeletal pain |
Abstract
PDF (Rus)
|
|
E. Yu. Polishchuk, A. E. Karateev |
| |
| Vol 16, No 3 (2022) |
Chronic musculoskeletal pain. Leading symptom or comorbid pathology? |
Abstract
PDF (Rus)
|
|
Yu. A. Olyunin |
| |
| Vol 16, No 3 (2022) |
Clinical and histological variants of panniculitis in children |
Abstract
PDF (Rus)
|
|
O. N. Egorova, G. M. Tarasova, A. V. Datsina |
| |
| Vol 16, No 2 (2022) |
Significance of hyperferritinemia as a diagnostic and prognostic biomarker |
Abstract
PDF (Rus)
|
|
M. I. Kaleda, E. S. Fedorov |
| |
| Vol 16, No 2 (2022) |
Clinical significance of antibodies to the phosphatidylserine/prothrombin complex |
Abstract
PDF (Rus)
|
|
T. M. Reshetnyak, F. A. Cheldieva, M. V. Cherkasova, A. M. Lila |
| |
| Vol 16, No 2 (2022) |
The problem of long-term pain control in chronic rheumatic diseases |
Abstract
PDF (Rus)
|
|
E. Yu. Polishchuk, A. E. Karateev |
| |
| Vol 16, No 2 (2022) |
Analysis of the mechanisms of development of neurorheumatological consequences of COVID-19 and the possibility of their pharmacological correction |
Abstract
PDF (Rus)
|
|
I. V. Sarvilina, A. M. Lila, O. A. Gromova, I. Yu. Torshin, O. A. Shavlovskaya, E. A. Taskina |
| |
| Vol 16, No 2 (2022) |
Symptomatic delayed-acting drugs (SYSADOA): new applications |
Abstract
PDF (Rus)
|
|
A. M. Lila, E. A. Taskina, L. I. Alekseeva, N. G. Kashevarova |
| |
| Vol 16, No 1 (2022) |
Morphological features of lobular panniculitis in systemic lupus erythematosus and dermatomyositis |
Abstract
PDF (Rus)
|
|
I. D. Musatov, S. G. Radenska-Lopovok, O. N. Egorova, A. A. Kolomeichuk |
| |
| Vol 16, No 1 (2022) |
Radiologic methods as a tool for monitoring axial spondyloarthritis in real clinical practice |
Abstract
PDF (Rus)
|
|
T. V. Dubinina, A. B. Demina |
| |
| Vol 16, No 1 (2022) |
Intra-articular injections in the treatment of osteoarthritis |
Abstract
PDF (Rus)
|
|
Yu. A. Olyunin, I. N. Schendrigin |
| |
| Vol 16, No 1 (2022) |
Therapy with non-steroidal anti-inflammatory drugs and the quality of life of patients with rheumatic diseases |
Abstract
PDF (Rus)
|
|
E. Yu. Polishchuk, A. E. Karateev, V. N. Amirdzhanova |
| |
| Vol 16, No 1 (2022) |
Important aspects of osteoarthritis therapy during the COVID-19 pandemic |
Abstract
PDF (Rus)
|
|
A. M. Lila, A. G. Chuchalin, I. Yu. Torshin, O. A. Gromova |
| |
| Vol 15, No 6 (2021) |
Objective assessment of the damaging effect of glucocorticoids (toxicity index) in patients with systemic lupus erythematosus |
Abstract
PDF (Rus)
|
|
N. Yu. Nikishina, E. V. Ermolaeva, A. A. Mesnyankina, E. A. Aseeva, S. K. Soloviev, B. Sh. Isaeva, G. M. Koylubaeva, A. M. Lila |
| |
| Vol 15, No 6 (2021) |
Analysis of the therapeutic benefits of symptomatic slow acting drugs in osteoarthritis: emphasis on structural-modifying action |
Abstract
PDF (Rus)
|
|
I. B. Belyaeva, V. I. Mazurov, E. A. Trofimov |
| |
| Vol 15, No 6 (2021) |
Role of fatty acids in inflammation, atherosclerosis, metabolic disorders and gout |
Abstract
PDF (Rus)
|
|
M. A. Gromova, V. V. Tsurko, O. A. Kislyak, E. V. Kiseleva |
| |
| Vol 15, No 5 (2021) |
Pharmacoinformation studies of chondroprotectors |
Abstract
PDF (Rus)
|
|
A. M. Lila, I. Yu. Torshin, A. N. Gromov, V. A. Semenov, O. A. Gromova |
| |
| Vol 15, No 5 (2021) |
Netosis in the pathogenesis of antiphospholipid syndrome and systemic lupus erythematosus |
Abstract
PDF (Rus)
|
|
K. S. Nurbaeva, T. M. Reshetnyak, A. M. Lila |
| |
| Vol 15, No 5 (2021) |
Local and generalized bone loss in rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
P. S. Kovalenko, N. I. Kolganova, I. S. Dydykina, P. O. Kozhevnikova, M. Yu. Blank |
| |
| Vol 15, No 5 (2021) |
Use of botulinum toxin type A in rheumatic diseases |
Abstract
PDF (Rus)
|
|
O. N. Egorova, B. S. Belov, E. G. Sazhina |
| |
| Vol 15, No 4 (2021) |
Prospects for the use of belimumab in lupus nephritis |
Abstract
PDF (Rus)
|
|
N. L. Kozlovskaya, S. K. Soloviev, E. A. Aseeva |
| |
| Vol 15, No 4 (2021) |
Assessment of the activity and organ damage in antiphospholipid syndrome |
Abstract
PDF (Rus)
|
|
F. A. Cheldieva, T. M. Reshetnyak, A. M. Lila |
| |
| Vol 15, No 4 (2021) |
Pharmacotherapy of gout – modern approaches and prospects |
Abstract
PDF (Rus)
|
|
P. A. Lebedev, A. A. Garanin, N. L. Novichkova |
| |
| Vol 15, No 4 (2021) |
Tapentadol in acute pain: a review of the results of international studies |
Abstract
PDF (Rus)
|
|
V. V. Nikoda |
| |
| Vol 15, No 4 (2021) |
Efficacy of Chondroitin Sulfate in Patients with Knee and Hip Osteoarthritis |
Abstract
PDF (Rus)
|
|
E. P. Sharapova, E. A. Taskina, N. G. Kashevarova, L. I. Alekseeva, A. M. Lila |
| |
| Vol 15, No 3 (2021) |
Forecasting index of unfavorable outcomes of systemic lupus erythematosus |
Abstract
PDF (Rus)
|
|
E. A. Aseeva, N. Yu. Nikishina, A. A. Mesnyankina, S. K. Solovyev, B. Sh. Isaeva, G. M. Koilubaeva, A. M. Lila |
| |
| Vol 15, No 3 (2021) |
Analysis of safety of bioactive concentrate of small sea fish therapy in comorbid patients with osteoarthritis |
Abstract
PDF (Rus)
|
|
O. V. Zimnitskaya, M. M. Petrova, P. A. Shesternya |
| |
| Vol 15, No 2 (2021) |
The Prospects of tumor necrosis factor α inhibitors use in patients with COVID-19 |
Abstract
PDF (Rus)
|
|
E. S. Aronova, B. S. Belov |
| |
| Vol 15, No 2 (2021) |
Recent advances and prospects of axial spondyloarthritis / ankylosing spondylitis treatment |
Abstract
PDF (Rus)
|
|
Sh. F. Erdes |
| |
| Vol 15, No 2 (2021) |
Inhibitors of interleukin 17A in the treatment of psoriatic arthritis: what's new? |
Abstract
PDF (Rus)
|
|
Т. V. Korotaeva |
| |
| Vol 15, No 2 (2021) |
Osteoarthritis background therapy: current view on the glucosamine and chondroitin therapy |
Abstract
PDF (Rus)
|
|
L. I. Alekseeva, A. M. Lila |
| |
| Vol 15, No 2 (2021) |
Synovitis in osteoarthritis: the current state of the problem |
Abstract
PDF (Rus)
|
|
I. S. Dydykina, E. V. Arutyunova, P. S. Kovalenko, E. V. Nikolaeva, A. V. Naumov |
| |
| Vol 15, No 2 (2021) |
Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs |
Abstract
PDF (Rus)
|
|
E. V. Zonova |
| |
| Vol 15, No 1 (2021) |
Autologous hematopoietic stem cell transplantation in the treatment of systemic sclerosis. Part 2. Safety and complications |
Abstract
PDF (Rus)
|
|
O. B. Ovsyannikova, L. P. Ananyeva, O. A. Koneva, L. A. Garzanova, O. V. Desinova, R. U. Shayakhmetova, M. N. Starovoitova, A. M. Lila |
| |
| Vol 15, No 1 (2021) |
New aspects of pain management in acute and chronic inflammatory syndromes |
Abstract
PDF (Rus)
|
|
V. N. Amirdjanova, A. Е. Karateev |
| |
| 1 - 100 of 248 Items |
1 2 3 > >>
|
